MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

Duncan Aust, Ph.D. Joins DPT Research and Development

Release issued 5th December 2002

San Antonio, Texas — DPT's Chief Scientific Officer, Dr. Braham Shroot, recently appointed Dr. Duncan Aust as Vice President of DPT Research and Development (R & D). Dr. Aust graduated from King's College London (University of London) in 1994 with a Ph.D. in Biotechnology. After graduating, Dr. Aust's career began as the Director of Development & Special Analytical Services with the Collaborative Group in New York, where he was responsible for R&D and Special Analytical Services and was a key contributor to manufacturing, production and new business development needs.

Dr. Aust has been instrumental in the development and launch of many new topical and biotech products during his fifteen years in the scientific community. Having negotiated numerous contracts and business partnerships with US, European and Asian companies. Dr. Aust holds numerous patents in the field of topical delivery systems and formulations, and has helped numerous customers translate new technologies or client ideas into marketable products.

Dr. Aust will join the ranks of one of the fastest growing R & D groups in the industry dedicated to dermatology, skin diseases and wound and tissue management. DPT's scientific staff comes from 15 nations, including Germany, England, Canada, China, India and the United States with plans to double its staff within the next three years. With a heritage dating back to 1938, DPT is an independent, privately-owned company that strives to build long-term partnerships. DPT specializes in the full service development, manufacturing, packaging and worldwide distribution of semisolid and liquid, Rx, OTC and biotech products. DPT's full range of packaging services include solid, semisolid and liquid dosage forms. DPT customers include most of the top Fortune 500 pharmaceutical and consumer products companies, as well as biotechnology and start-up companies. Visit us at www.dptlabs.com.

###

Company details

If you want to find out more about the company visit DPT Laboratories profile.

Latest DPT Laboratories press releases

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
The countdown has started...
ShareVault
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us